iHEART-SA Intervention Study
iHEART-SA
The Integrating HIV and hEART Health in South Africa Intervention Study
1 other identifier
interventional
4,378
1 country
1
Brief Summary
Using qualitative data during the formative phase the IHEART-SA research study filled deficiencies in knowledge regarding: 1) what barriers exist to integrating hypertension care within the HIV care setting in South Africa and, 2) how a hypertension care intervention can be adapted to effectively and sustainably function in this care setting. These data have been used to design a context-relevant intervention package for implementation in the next phase of effectiveness-implementation testing, answering the research question: How does an intervention aimed at enhancing hypertension diagnosis and management in people living with HIV improve the delivery of guideline-recommended care in primary healthcare clinics in Gauteng, South Africa, and hypertension control among patients? The study will use an effectiveness-implementation study design. This design allows for the testing of strategies to promote integration of proven interventions in real-world practice (i.e., implementation strategies), while simultaneously assessing clinical effectiveness (i.e., patient level outcomes). For this the study will use a randomized cluster stepped-wedge study design where nine clinics (grouped in clusters of three) will be assigned to a time at which they initiate the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hypertension
Started Jun 2023
Typical duration for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 12, 2023
CompletedFirst Posted
Study publicly available on registry
May 6, 2023
CompletedStudy Start
First participant enrolled
June 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2025
CompletedDecember 10, 2025
December 1, 2025
2 years
April 12, 2023
December 3, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Healthcare worker
Difference in percentage of patient visits with recorded BP measurement between intervention and control clinics
24 months
Patient
Difference in mean systolic BP between the intervention and control conditions
12 months
Secondary Outcomes (8)
Healthcare worker implementation
24 months
Healthcare worker adoption
24 months
Healthcare worker maintenance - BP measurement
12 months
Healthcare worker satisfaction
24 months
Healthcare worker costing
27 months
- +3 more secondary outcomes
Study Arms (2)
Intervention
OTHERCluster of clinics receiving the five investigational interventions
Control
NO INTERVENTIONStandard of care
Interventions
1. The intervention package prioritizes information and quality management with a focus on HTN screening, diagnosis, and treatment. From the point-of-care, flow charts placed in the patient file will ensure that vitals are performed in accordance with national guidelines. 2. The care coordinator will present data to clinic staff in multi-disciplinary meetings, providing an opportunity for programmatic feedback and discussion. 3. Patients will be encouraged to complete the vital signs measurements at each clinic visit. They will be provided with their BP readings and given info about what their reading means. They will be issued with pocket sized color coded booklets providing info on the measurement and what to do to control their BP. 4. Task shifting: A care coordinator will be the champion of the intervention package for the clinic. 5. All staff will receive apt training on how to use the patient flow chart, info management system and how to respond to abnormal BP values.
Eligibility Criteria
You may qualify if:
- Healthcare workers:
- Adult \>18 years men and women working in clinical roles at the selected clinics
- Provide informed consent (only those participating in the qualitative components)
- Patients:
- Adults \>18 years living with HIV and hypertension
- Enrolled in the study clinic
- Willing and able to provide informed consent
You may not qualify if:
- Patients:
- Unable or unwilling to provide informed consent
- Planning to relocate or change service providers/clinics
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emory Universitycollaborator
- Massachusetts General Hospitalcollaborator
- UMC Utrechtcollaborator
- University of Witwatersrand, South Africalead
Study Sites (1)
Sunnyside Office Park
Johannesburg, Gauteng, 2193, South Africa
Related Publications (1)
Galaviz KI, Patel SA, Siedner MJ, Goss CW, Gumede SB, Johnson LC, Ordonez CE, Laxy M, Klipstein-Grobusch K, Heine M, Masterson M, Mody A, Venter WDF, Marconi VC, Ali MK, Lalla-Edward ST. Integrating hypertension detection and management in HIV care in South Africa: protocol for a stepped-wedged cluster randomized effectiveness-implementation hybrid trial. Implement Sci Commun. 2024 Oct 14;5(1):115. doi: 10.1186/s43058-024-00640-6.
PMID: 39402688DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Willem DF Venter, MD, PHD
Ezintsha, University of the Witwatersrand
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- There is no masking. This is an intervention study without drugs. Intervention comprises training and education, data and feedback, and task shifting.
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Executive Director
Study Record Dates
First Submitted
April 12, 2023
First Posted
May 6, 2023
Study Start
June 1, 2023
Primary Completion
May 31, 2025
Study Completion
August 31, 2025
Last Updated
December 10, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share